rss
J Clin Pathol 54:54-62 doi:10.1136/jcp.54.1.54

Why oral calcium supplements may reduce renal stone disease: report of a clinical pilot study

Table 2

Phosphate, calcium, and oxalate excretion in 1066 individual 24 hour urine samples collected by 246 patients over a five year period

Phosphate excretion (mmol/24 h) Calcium excretion (mmol/24 h) Oxalate excretion (μmol/24 h) Calcium × oxalate product
Samples were coded “1” to “5” if they were collected at the same time of the year as the periods of the trial (June to July, July to mid August, mid August to mid September, mid September to November, and November to December, respectively).
Mean results are presented with 95% confidence intervals.
p Values were assessed using the Bonferroni post to hoc test after two way ANOVA (results classified by “period number” and “patient number”).
Period 1 34.5 (32.5 to 36.7) 6.6 (6.2 to 7.1) 375 (352 to 400) 2496 (2239 to 2782)
Period 2 35.5 (33.8 to 37.3) 7.0 (6.5 to 7.6) 368 (347 to 392) 2586 (2327 to 2874)
Period 3 34.7 (31.9 to 37.7) 6.5 (5.9 to 7.1) 381 (3347 to 418) 2468 (2139 to 2848)
Period 4 32.7 (31.5 to 33.8) 6.1 (5.8 to 6.4) 364 (345 to 385) 2231 (2060 to 2417)
Period 5 31.4 (29.8 to 33.1) 5.8 (5.3 to 6.4) 398 (372 to 427) 2325 (2065 to 2618)
p Values 1 v 5, p <0.01 1 v 4, p <0.01 2 v 4, p <0.01
2 v 4, p <0.001 1 v 5, p <0.001
2 v 5, p <0.001 2 v 4, p <0.0001
2 v 5, p < 0.001

This Article

Latest from JCP Education

Latest from JCP Education

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JCP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

  • Latest Pathology jobs

    Latest Pathology jobs